Historical record - last NADAC effective date: 4/17/2024
Product Information
CLOTRIMAZOLE 1% SOLUTION is a generic product labeled by ScieGen Pharmaceuticals Inc., priced at $0.6167 per ML under NDC 50228050261. Its NADAC has been published 5 times since Apr 10, 2024.
FDA first approved this application on Oct 16, 2023. Its Orange Book therapeutic-equivalence code is AT.
Strength
10 mg/mL
Manufacturer
ScieGen Pharmaceuticals Inc.NDC
50228050261
Classification
Generic
Dosage Form
SOLUTION
Route
TOPICAL
Effective Date
4/17/2024
Active Ingredients
CLOTRIMAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA216569FDA Approved
10/16/2023
TE Code
AT
On Market Since
10/16/2023
Pharmacological Classes
Price Statistics
The NADAC for CLOTRIMAZOLE 1% SOLUTION has been published 5 times since Apr 10, 2024, and over the history we have for it it has declined 36.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6167 per ML |
|---|---|
| All-time high | $0.9779 (Apr 10, 2024) |
| All-time low | $0.6167 (Apr 17, 2024) |
| Median price | $0.6167 |
| Average price | $0.6890 |
| Largest weekly change | -36.9% (Apr 17, 2024) |
| Weeks tracked | 5 |
| Tracking since | Apr 10, 2024 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-36.9%
Last surveyed May 8, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 31% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
ScieGen Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Clotrimazole Topical Solution USP, 1% market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Azole Antifungal class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLOTRIMAZOLE 1% SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for CLOTRIMAZOLE 1% SOLUTION, manufactured by ScieGen Pharmaceuticals Inc., is $0.6167 per ML (NDC 50228050261), effective May 8, 2024.
How has the price of CLOTRIMAZOLE 1% SOLUTION changed over time?
Over the history we have for it, the NADAC for CLOTRIMAZOLE 1% SOLUTION has declined 36.9%. It has been tracked across 5 weekly CMS publications since Apr 10, 2024.
What are the highest and lowest recorded NADAC prices for CLOTRIMAZOLE 1% SOLUTION?
Since Apr 10, 2024, the NADAC for CLOTRIMAZOLE 1% SOLUTION has ranged from a low of $0.6167 (Apr 17, 2024) to a high of $0.9779 (Apr 10, 2024), with a median of $0.6167 per ML.
Are there cheaper alternatives to CLOTRIMAZOLE 1% SOLUTION?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CLOTRIMAZOLE 1% SOLUTION, is $0.4257 per ML — about 31% below CLOTRIMAZOLE 1% SOLUTION.
Who manufactures CLOTRIMAZOLE 1% SOLUTION?
CLOTRIMAZOLE 1% SOLUTION (NDC 50228050261) is labeled by ScieGen Pharmaceuticals Inc., and CMS classifies it as a generic product.